Literature DB >> 19751717

Enzyme-linked immunoabsorbent assay for detection of human serine protease corin in blood.

Aviva Peleg1, Allan S Jaffe, Yonathan Hasin.   

Abstract

BACKGROUND: Corin is a tissue type II transmembrane protein that converts pro-atrial natriuretic peptides and pro-brain natriuretic peptide to their active forms. Despite their protecting effect, high levels of these peptides indicate a bad prognosis. One of the possible explanations to this paradox is reduced cleavage due to low corin levels. The purpose of this study was to develop an assay to detect blood levels of corin.
METHODS: ELISA was developed using rat monoclonal antibody to recombinant human corin as capture antibody, and biotinylated goat anti-human corin as detection antibody.
RESULTS: Based on known corin concentration as standards, the ideal capture antibody concentration was 500 ng/ml, and 200 ng/ml for detection antibody. The coefficient of variation was 5.7% for inter-assay and 3.9% for intra-assay precision. Corin levels were stable when stored at room temperature for 1 day, for 3 days at 4 degrees C or up to 1 year in -35 degrees C. Human serum corin levels were reproducibly measured in individuals and found to range from 296 to 2590 pg/ml.
CONCLUSIONS: The immunoabsorbent assay developed in this study can accurately and reliably determine human serum corin levels, and is suitable for simple screening of corin in clinical practice.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19751717     DOI: 10.1016/j.cca.2009.09.004

Source DB:  PubMed          Journal:  Clin Chim Acta        ISSN: 0009-8981            Impact factor:   3.786


  21 in total

1.  Human corin isoforms with different cytoplasmic tails that alter cell surface targeting.

Authors:  Xiaofei Qi; Jingjing Jiang; Mingqing Zhu; Qingyu Wu
Journal:  J Biol Chem       Date:  2011-04-25       Impact factor: 5.157

2.  Ectodomain shedding and autocleavage of the cardiac membrane protease corin.

Authors:  Jingjing Jiang; Shannon Wu; Wei Wang; Shenghan Chen; Jianhao Peng; Xiumei Zhang; Qingyu Wu
Journal:  J Biol Chem       Date:  2011-02-02       Impact factor: 5.157

Review 3.  Corin in natriuretic peptide processing and hypertension.

Authors:  Yiqing Zhou; Qingyu Wu
Journal:  Curr Hypertens Rep       Date:  2014-02       Impact factor: 5.369

Review 4.  The paradox of low BNP levels in obesity.

Authors:  Aldo Clerico; Alberto Giannoni; Simona Vittorini; Michele Emdin
Journal:  Heart Fail Rev       Date:  2012-01       Impact factor: 4.214

Review 5.  Role of corin in the regulation of blood pressure.

Authors:  Hui Li; Yue Zhang; Qingyu Wu
Journal:  Curr Opin Nephrol Hypertens       Date:  2017-03       Impact factor: 2.894

6.  Glycosylation and processing of pro-B-type natriuretic peptide in cardiomyocytes.

Authors:  Jianhao Peng; Jingjing Jiang; Wei Wang; Xiaofei Qi; Xue-Long Sun; Qingyu Wu
Journal:  Biochem Biophys Res Commun       Date:  2011-07-06       Impact factor: 3.575

7.  Corin mutation R539C from hypertensive patients impairs zymogen activation and generates an inactive alternative ectodomain fragment.

Authors:  Ningzheng Dong; Chaodong Fang; Yizhi Jiang; Tiantian Zhou; Meng Liu; Jianping Zhou; Jianzhong Shen; Koichi Fukuda; Jun Qin; Qingyu Wu
Journal:  J Biol Chem       Date:  2013-01-31       Impact factor: 5.157

Review 8.  Role of corin and atrial natriuretic peptide in preeclampsia.

Authors:  Y Zhou; Q Wu
Journal:  Placenta       Date:  2012-12-02       Impact factor: 3.481

9.  Plasma soluble corin in patients with heart failure.

Authors:  Ningzheng Dong; Shenghan Chen; Junhua Yang; Lizhen He; Peng Liu; Dongdong Zheng; Lin Li; Yiqing Zhou; Changgeng Ruan; Edward Plow; Qingyu Wu
Journal:  Circ Heart Fail       Date:  2010-01-08       Impact factor: 8.790

10.  Corin mutations K317E and S472G from preeclamptic patients alter zymogen activation and cell surface targeting. [Corrected].

Authors:  Ningzheng Dong; Tiantian Zhou; Yue Zhang; Meng Liu; Hui Li; Xiaoyi Huang; Zhenzhen Liu; Yi Wu; Koichi Fukuda; Jun Qin; Qingyu Wu
Journal:  J Biol Chem       Date:  2014-05-14       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.